Self-management of Anticoagulation Treatment
- Conditions
- Long-term Oral Anticoagulant Therapy
- Interventions
- Other: Training
- Registration Number
- NCT02371772
- Lead Sponsor
- Una Ørvim Sølvik
- Brief Summary
The aim of the study was to compare self-management of anticoagulant treatment with conventional anticoagulant treatment in Norway.
- Detailed Description
Patients (n=23) on anticoagulant treatment with warfarin participated in a 27 weeks training program where they learned how to analyse International Normalised Ratio (INR) using the point-of-care instrument CoaguChek® XS and dose warfarin. The patients had to display their skills through a test before considered self-managing. They continued to measure INR weekly for 28 weeks. All INR values during the training program and self-control period were collected. In addition, the patients were told to notify if they had any complications during this period. Ten INR values and complications before enrolment was collected from INR cards and/or their general practioner. The participant filled in a quality of life-questioner at enrolment and after 28 weeks of self-management.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 23
- on life-long oral anticoagulation therapy
- Live in Bergen municipality
- Judged to be qualified for patient self-management anticoagulation treatment by their GP
- Motivated to follow the training program
- Drug abuse
- Liver disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Self-management anticoagulation treatment Training Trained to monitor INR and dose warfarin
- Primary Outcome Measures
Name Time Method Change in Time in therapeutic range (TTR) From 39 weeks before enrolment until 28 weeks of self management
- Secondary Outcome Measures
Name Time Method Change in number of complications From 39 weeks before enrolment until 28 weeks of self management